Portfolio Holdings Detail for ISIN IE00BMX0DF60
Stock Name / Fund iShares US Medical Devices UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker UMDV.AS(USD) CXE
ETF Ticker UMDV(USD) Euronext Amsterdam

Holdings detail for SRDX

Stock Name	SurModics Inc
Ticker	SRDX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US8688731004
LEI	549300H76KXCAAGUS878

Show aggregate SRDX holdings

News associated with SRDX

Surmodics (NASDAQ:SRDX) Trading 8.7% Higher on Earnings Beat: Surmodics, Inc. (NASDAQ:SRDX – Get Free Report) rose 8.7% during trading on Monday after the company announced better than expected quarterly earnings. The stock traded as high as $38.33 and last traded at $38.48. Approximately 194,800 shares traded hands during mid-day trading, an increase of 10% from the average daily volume of 176,503 shares. The […] - 2025-08-13 02:22:56
Surmodics (NASDAQ:SRDX) Receives “Market Perform” Rating from Barrington Research: Barrington Research reiterated their market perform rating on shares of Surmodics (NASDAQ:SRDX – Free Report) in a research note published on Monday,Benzinga reports. Separately, Needham & Company LLC reiterated a “hold” rating on shares of Surmodics in a research note on Wednesday, April 30th. Read Our Latest Stock Report on Surmodics Surmodics Trading Up 7.3% […] - 2025-08-12 04:47:07
Wells Fargo & Company MN Raises Holdings in Surmodics, Inc. (NASDAQ:SRDX): Wells Fargo & Company MN increased its position in shares of Surmodics, Inc. (NASDAQ:SRDX – Free Report) by 40.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 7,032 shares of the company’s stock after buying an additional 2,041 shares during the quarter. Wells Fargo & Company MN’s holdings in Surmodics were worth $278,000 […] - 2025-05-07 04:52:54
Marshall Wace LLP Purchases 19,635 Shares of Surmodics, Inc. (NASDAQ:SRDX): Marshall Wace LLP increased its position in Surmodics, Inc. (NASDAQ:SRDX – Free Report) by 231.0% in the 4th quarter, Holdings Channel reports. The firm owned 28,135 shares of the company’s stock after buying an additional 19,635 shares during the quarter. Marshall Wace LLP’s holdings in Surmodics were worth $1,114,000 as of its most recent filing […] - 2025-04-30 04:59:02
Barclays PLC Buys 19,251 Shares of Surmodics, Inc. (NASDAQ:SRDX): Barclays PLC grew its stake in shares of Surmodics, Inc. (NASDAQ:SRDX – Free Report) by 21.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 108,001 shares of the company’s stock after buying an additional 19,251 shares during the period. Barclays PLC […] - 2025-04-28 05:01:23
Surmodics (NASDAQ:SRDX) Upgraded at Lake Street Capital: Lake Street Capital upgraded shares of Surmodics (NASDAQ:SRDX – Free Report) from a hold rating to a buy rating in a report published on Friday morning, Marketbeat.com reports. Lake Street Capital currently has $43.00 price target on the stock. Several other equities research analysts have also recently commented on SRDX. StockNews.com started coverage on shares […] - 2025-03-10 03:56:53
New York Life Investment Management LLC Sells 2,584 Shares of Surmodics, Inc. (NASDAQ:SRDX): New York Life Investment Management LLC decreased its position in shares of Surmodics, Inc. (NASDAQ:SRDX – Free Report) by 14.1% during the fourth quarter, Holdings Channel.com reports. The fund owned 15,784 shares of the company’s stock after selling 2,584 shares during the quarter. New York Life Investment Management LLC’s holdings in Surmodics were worth $625,000 […] - 2025-03-05 08:04:59
Head to Head Comparison: Surmodics (NASDAQ:SRDX) vs. Neuronetics (NASDAQ:STIM): Neuronetics (NASDAQ:STIM – Get Free Report) and Surmodics (NASDAQ:SRDX – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, earnings, risk, valuation, institutional ownership and profitability. Analyst Ratings This is a breakdown of current ratings […] - 2025-02-11 04:52:54

iShares US Medical Devices UCITS ETF SRDX holdings

Date	Number of SRDX Shares Held	Base Market Value of SRDX Shares	Local Market Value of SRDX Shares	Change in SRDX Base Value	Current Price per SRDX Share Held	Previous Price per SRDX Share Held
2025-11-19 (Wednesday)	1,950	USD 83,811	USD 83,811	USD 0	USD 42.98	USD 42.98
2025-11-18 (Tuesday)	1,950	USD 83,811	USD 83,811	USD 292	USD 42.98	USD 42.8303
2025-11-17 (Monday)	1,950	USD 83,519	USD 83,519	USD 2,379	USD 42.8303	USD 41.6103

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of SRDX by Blackrock for IE00BMX0DF60

Show aggregate share trades of SRDX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-06 SELL -36 26.420* 32.42 Profit of 1,167 on sale
2025-11-04 BUY 18 27.500* 32.46
2025-10-30 SELL -54 27.810 26.750 26.856 USD -1,450 32.52 Profit of 306 on sale
2025-10-23 SELL -18 27.500 28.120 28.058 USD -505 32.64 Profit of 82 on sale
2025-10-22 BUY 36 28.280 28.460 28.442 USD 1,024 32.65
2025-10-20 BUY 18 28.130 28.310 28.292 USD 509 32.69
2025-10-16 BUY 18 28.000 28.570 28.513 USD 513 32.74
2025-10-13 SELL -17 27.920 28.660 28.586 USD -486 32.80 Profit of 72 on sale
2025-09-25 BUY 128 30.820 31.090 31.063 USD 3,976 32.95
2025-08-22 SELL -60 37.190 37.770 37.712 USD -2,263 32.92 Loss of -287 on sale
2025-07-07 SELL -16 29.660 31.060 30.920 USD -495 32.69 Profit of 28 on sale
2025-06-27 SELL -32 28.810 29.500 29.431 USD -942 32.81 Profit of 108 on sale
2025-06-12 BUY 48 29.080 29.100 29.098 USD 1,397 33.09
2025-06-10 SELL -240 29.200 29.660 29.614 USD -7,107 33.15 Profit of 848 on sale
2025-06-09 SELL -304 29.160 29.490 29.457 USD -8,955 33.18 Profit of 1,131 on sale
2025-05-30 SELL -30 29.020 29.480 29.434 USD -883 33.34 Profit of 117 on sale
2025-05-19 BUY 15 29.480 29.970 29.921 USD 449 33.64
2025-05-09 SELL -90 26.760 27.370 27.309 USD -2,458 33.93 Profit of 596 on sale
2025-04-23 SELL -18 28.600 29.620 29.518 USD -531 34.54 Profit of 90 on sale
2025-04-17 SELL -18 27.570 28.860 28.731 USD -517 34.79 Profit of 109 on sale
2025-04-10 BUY 136 27.240 27.730 27.681 USD 3,765 35.13
2025-04-04 SELL -34 29.320 29.690 29.653 USD -1,008 35.41 Profit of 196 on sale
2025-04-02 SELL -34 30.760 30.990 30.967 USD -1,053 35.46 Profit of 153 on sale
2025-03-31 SELL -51 30.530 31.180 31.115 USD -1,587 35.56 Profit of 227 on sale
2025-03-19 SELL -16 30.000 30.130 30.117 USD -482 36.05 Profit of 95 on sale
2025-02-28 SELL -30 32.860 33.680 33.598 USD -1,008 37.17 Profit of 107 on sale
2025-02-05 BUY 54 33.850 34.240 34.201 USD 1,847 38.04
2025-02-04 BUY 72 33.620 34.430 34.349 USD 2,473 38.12
2025-01-29 SELL -17 35.780 36.000 35.978 USD -612 38.38 Profit of 41 on sale
2025-01-23 SELL -17 37.500 37.560 37.554 USD -638 38.47 Profit of 16 on sale
2025-01-17 SELL -17 36.880 36.940 36.934 USD -628 38.60 Profit of 28 on sale
2025-01-08 SELL -85 39.000 39.150 39.135 USD -3,326 38.85 Loss of -24 on sale
2025-01-02 SELL -30 39.680 40.000 39.968 USD -1,199 38.83 Loss of -34 on sale
2024-12-30 SELL -30 39.630 39.730 39.720 USD -1,192 38.81 Loss of -27 on sale
2024-12-04 BUY 42 39.910 40.030 40.018 USD 1,681 38.60
2024-12-03 SELL -15 39.490 39.550 39.544 USD -593 38.56 Loss of -15 on sale
2024-12-02 SELL -180 39.610 39.680 39.673 USD -7,141 38.52 Loss of -207 on sale
2024-11-29 SELL -300 39.450 39.580 39.567 USD -11,870 38.49 Loss of -324 on sale
2024-11-27 SELL -45 39.540 39.680 39.666 USD -1,785 38.39 Loss of -57 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-06	SELL	-36			26.420*		32.42 Profit of 1,167 on sale
2025-11-04	BUY	18			27.500*		32.46
2025-10-30	SELL	-54	27.810	26.750	26.856	USD -1,450	32.52 Profit of 306 on sale
2025-10-23	SELL	-18	27.500	28.120	28.058	USD -505	32.64 Profit of 82 on sale
2025-10-22	BUY	36	28.280	28.460	28.442	USD 1,024	32.65
2025-10-20	BUY	18	28.130	28.310	28.292	USD 509	32.69
2025-10-16	BUY	18	28.000	28.570	28.513	USD 513	32.74
2025-10-13	SELL	-17	27.920	28.660	28.586	USD -486	32.80 Profit of 72 on sale
2025-09-25	BUY	128	30.820	31.090	31.063	USD 3,976	32.95
2025-08-22	SELL	-60	37.190	37.770	37.712	USD -2,263	32.92 Loss of -287 on sale
2025-07-07	SELL	-16	29.660	31.060	30.920	USD -495	32.69 Profit of 28 on sale
2025-06-27	SELL	-32	28.810	29.500	29.431	USD -942	32.81 Profit of 108 on sale
2025-06-12	BUY	48	29.080	29.100	29.098	USD 1,397	33.09
2025-06-10	SELL	-240	29.200	29.660	29.614	USD -7,107	33.15 Profit of 848 on sale
2025-06-09	SELL	-304	29.160	29.490	29.457	USD -8,955	33.18 Profit of 1,131 on sale
2025-05-30	SELL	-30	29.020	29.480	29.434	USD -883	33.34 Profit of 117 on sale
2025-05-19	BUY	15	29.480	29.970	29.921	USD 449	33.64
2025-05-09	SELL	-90	26.760	27.370	27.309	USD -2,458	33.93 Profit of 596 on sale
2025-04-23	SELL	-18	28.600	29.620	29.518	USD -531	34.54 Profit of 90 on sale
2025-04-17	SELL	-18	27.570	28.860	28.731	USD -517	34.79 Profit of 109 on sale
2025-04-10	BUY	136	27.240	27.730	27.681	USD 3,765	35.13
2025-04-04	SELL	-34	29.320	29.690	29.653	USD -1,008	35.41 Profit of 196 on sale
2025-04-02	SELL	-34	30.760	30.990	30.967	USD -1,053	35.46 Profit of 153 on sale
2025-03-31	SELL	-51	30.530	31.180	31.115	USD -1,587	35.56 Profit of 227 on sale
2025-03-19	SELL	-16	30.000	30.130	30.117	USD -482	36.05 Profit of 95 on sale
2025-02-28	SELL	-30	32.860	33.680	33.598	USD -1,008	37.17 Profit of 107 on sale
2025-02-05	BUY	54	33.850	34.240	34.201	USD 1,847	38.04
2025-02-04	BUY	72	33.620	34.430	34.349	USD 2,473	38.12
2025-01-29	SELL	-17	35.780	36.000	35.978	USD -612	38.38 Profit of 41 on sale
2025-01-23	SELL	-17	37.500	37.560	37.554	USD -638	38.47 Profit of 16 on sale
2025-01-17	SELL	-17	36.880	36.940	36.934	USD -628	38.60 Profit of 28 on sale
2025-01-08	SELL	-85	39.000	39.150	39.135	USD -3,326	38.85 Loss of -24 on sale
2025-01-02	SELL	-30	39.680	40.000	39.968	USD -1,199	38.83 Loss of -34 on sale
2024-12-30	SELL	-30	39.630	39.730	39.720	USD -1,192	38.81 Loss of -27 on sale
2024-12-04	BUY	42	39.910	40.030	40.018	USD 1,681	38.60
2024-12-03	SELL	-15	39.490	39.550	39.544	USD -593	38.56 Loss of -15 on sale
2024-12-02	SELL	-180	39.610	39.680	39.673	USD -7,141	38.52 Loss of -207 on sale
2024-11-29	SELL	-300	39.450	39.580	39.567	USD -11,870	38.49 Loss of -324 on sale
2024-11-27	SELL	-45	39.540	39.680	39.666	USD -1,785	38.39 Loss of -57 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SRDX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	25,144	10,553	64,365	39.1%
2025-09-18	17,155	0	47,640	36.0%
2025-09-17	10,184	0	58,721	17.3%
2025-09-16	10,275	0	79,664	12.9%
2025-09-15	10,231	0	45,078	22.7%
2025-09-12	9,579	0	35,153	27.2%
2025-09-11	5,775	0	26,950	21.4%
2025-09-10	12,372	0	81,713	15.1%
2025-09-09	9,000	0	86,148	10.4%
2025-09-08	9,236	0	46,207	20.0%
2025-09-05	7,629	0	31,668	24.1%
2025-09-04	21,635	0	101,877	21.2%
2025-09-03	16,586	0	51,928	31.9%
2025-09-02	28,102	0	101,377	27.7%
2025-08-29	8,912	0	38,057	23.4%
2025-08-28	4,634	0	32,754	14.1%
2025-08-27	10,250	0	88,382	11.6%
2025-08-26	17,588	0	104,000	16.9%
2025-08-25	7,655	0	32,620	23.5%
2025-08-22	45,118	1,600	378,433	11.9%
2025-08-21	53,321	8,400	252,507	21.1%
2025-08-20	49,580	0	207,734	23.9%
2025-08-19	52,902	0	240,061	22.0%
2025-08-18	17,648	0	269,467	6.5%
2025-08-15	133,385	0	226,582	58.9%
2025-08-14	33,169	0	139,098	23.8%
2025-08-13	31,628	0	105,918	29.9%
2025-08-12	25,514	0	73,902	34.5%
2025-08-11	43,738	0	132,228	33.1%
2025-08-08	13,018	0	91,003	14.3%
2025-08-07	24,177	0	63,137	38.3%
2025-08-06	17,601	0	31,009	56.8%
2025-08-05	31,676	0	61,953	51.1%
2025-08-04	55,244	0	111,956	49.3%
2025-08-01	30,753	0	61,802	49.8%
2025-07-31	33,553	0	160,196	20.9%
2025-07-30	29,048	0	87,778	33.1%
2025-07-29	34,291	0	154,528	22.2%
2025-07-28	57,621	1,517	363,975	15.8%
2025-07-25	43,681	0	150,696	29.0%
2025-07-24	6,269	0	27,758	22.6%
2025-07-23	11,321	0	41,439	27.3%
2025-07-22	8,657	0	38,382	22.6%
2025-07-21	8,914	0	17,864	49.9%
2025-07-18	7,362	0	20,306	36.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam